It's protective language. They can't say with certainty as the product hasn't passed a phase 3 study yet with a placebo control. So they have to say possibly a game changer or possibly a cure.
Look at reports of the great majority of abstracts for P1 trials that suggest benefit. Most authors are extremely conservative with their claims. The data has to be unequivocally positive to claim benefit.